Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
Image: NIRBA will engage scientists and clinicians from leading institutions like NUS, A*STAR, NTU, and Duke-NUS Medical School, to build strategic ...
Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.
Net Loss: The net loss attributable to Serina for the year ended December 31, 2024 was $11.1 million, or $ (1.51) per basic and diluted share, compared to net income of $5.3 million, or $2.36 per ...
An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, according to a poster presented here. This molecular characterization may ...
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
The Republic aims to strengthen its RNA capabilities by providing a platform for key institutions here to collaborate. Read more at straitstimes.com.
Pharmaceutical Technology on MSN19h
FDA approves IND application for Everest’s cancer vaccineEVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...
Represents first project to enter the ECO Synthesis™ Innovation LabCore enzymes for ECO Synthesis™ technology have transitioned from research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback